BONE AND SOFT TISSUE CANCER (SARCOMA AND OSTEOSARCOMA): CLINICAL EXOME PANEL (Sec. & CNVs) – 33 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Bone and Soft Tissue Cancer Panel (Sarcoma and Osteosarcoma) is designed to detect genetic variants associated with hereditary syndromes that predispose individuals to developing bone and soft tissue sarcomas, including Li-Fraumeni syndrome, Lynch syndrome, neurofibromatosis type 1 syndrome, and alterations in genes related to the RB1 and TP53 pathways. These mutations confer a high risk of mesenchymal neoplasms and other associated tumors. Genetic testing allows for diagnostic confirmation, stratification of familial risk, and guidance of personalized surveillance and treatment strategies. Genes analyzed include: TP53, RB1, NF1, MLH1, MSH2, PMS2, SDHB, SDHD, TSC1, and others. You can consult the complete list of analyzed genes by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€